These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26341624)

  • 1. Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture.
    Page KR; Mezzalana E; MacDonald AJ; Zamuner S; De Nicolao G; van Maurik A
    J Pharmacol Exp Ther; 2015 Nov; 355(2):199-205. PubMed ID: 26341624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti-CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitus.
    Wiczling P; Rosenzweig M; Vaickus L; Jusko WJ
    J Clin Pharmacol; 2010 May; 50(5):494-506. PubMed ID: 19934031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patients.
    Vlasakakis G; Napolitano A; Barnard R; Brown K; Bullman J; Inman D; Keymeulen B; Lanham D; Leirens Q; MacDonald A; Mezzalana E; Page K; Patel M; Savage CO; Zamuner S; van Maurik A
    Br J Clin Pharmacol; 2019 Apr; 85(4):704-714. PubMed ID: 30566758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of TCR/CD3 complex CD3{varepsilon} chains of regulatory CD4+ T (Treg) lymphocytes: role in Treg differentiation in vitro and impact on Treg in vivo.
    Rojo JM; Ojeda G; Acosta YY; Montes-Casado M; Criado G; Portolés P
    J Leukoc Biol; 2014 Mar; 95(3):441-50. PubMed ID: 24212096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor.
    Ratcliffe MJ; Coggeshall KM; Newell MK; Julius MH
    J Immunol; 1992 Mar; 148(6):1643-51. PubMed ID: 1531842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
    Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
    Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
    J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface comodulation of CD4 and T cell receptor by anti-CD4 monoclonal antibody.
    Cole JA; McCarthy SA; Rees MA; Sharrow SO; Singer A
    J Immunol; 1989 Jul; 143(2):397-402. PubMed ID: 2786906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step.
    Boyer C; Auphan N; Luton F; Malburet JM; Barad M; Bizozzero JP; Reggio H; Schmitt-Verhulst AM
    Eur J Immunol; 1991 Jul; 21(7):1623-34. PubMed ID: 1829410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number.
    Graber M; Bockenstedt LK; Weiss A
    J Immunol; 1991 May; 146(9):2935-43. PubMed ID: 1826700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signals transduced by CD3epsilon, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro.
    Carleton M; Ruetsch NR; Berger MA; Rhodes M; Kaptik S; Wiest DL
    J Immunol; 1999 Sep; 163(5):2576-85. PubMed ID: 10452996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clustered CD3/TCR complexes do not transduce activation signals after bispecific monoclonal antibody-triggered lysis by cytotoxic T lymphocytes via CD3.
    Blank-Voorthuis CJ; Braakman E; Ronteltap CP; Tilly BC; Sturm E; Warnaar SO; Bolhuis RL
    J Immunol; 1993 Sep; 151(6):2904-14. PubMed ID: 8376761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of membrane TcR alpha beta and TcR gamma delta chain expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+ and CD4-CD8- lymphocytes.
    Scott CS; Richards SJ; Roberts BE
    Immunology; 1990 Jul; 70(3):351-6. PubMed ID: 2143170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM; Szewczuk MR
    Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone modulates TCR zeta chain expression and antigen receptor-mediated early signaling events in human T lymphocytes.
    Nambiar MP; Enyedy EJ; Fisher CU; Warke VG; Juang YT; Tsokos GC
    Cell Immunol; 2001 Feb; 208(1):62-71. PubMed ID: 11277620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen.
    Romano MF; Bisogni R; Lamberti A; Turco MC; Petrella A; Tassone P; Van Lier R; Formisano S; Venuta S
    Cell Immunol; 1994 Jul; 156(2):371-7. PubMed ID: 8025954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell activation by monoclonal antibodies directed to different epitopes on the human T cell receptor/CD3 complex: evidence for two different modes of activation.
    Schlitt HJ; Kurrle R; Wonigeit K
    Eur J Immunol; 1989 Sep; 19(9):1649-55. PubMed ID: 2477253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.